Upon inhibiting TNF-α and STAT3, the levels of pro-inflammatory cytokines decreased, revealing their modulatory roles in regulating inflammation in T2DM CD4+ cells. The gene discussed is STAT3; the disease is type 2 diabetes mellitus.